SEC 13F Intelligence

Enhancing Capital LLC / JNJ

Enhancing Capital LLC’s Johnson & Johnson Position

Does Enhancing Capital LLC own Johnson & Johnson (JNJ)? Yes — 15.6K shares worth $4M (+2.83% of its 13F portfolio) as of Q1 2026.

Position Value
$4M
Q1 2026
Shares
15.6K
% of Portfolio
+2.83%
Quarters Held
10
currently held

Position History JNJ

Reported value by quarter
Q4 ’21: $3MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ2 ’22Q3 ’22: $3MQ4 ’24: $2MQ4 ’24Q1 ’25: $3MQ2 ’25: $2MQ2 ’25Q3 ’25: $3MQ4 ’25: $3MQ4 ’25Q1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202615.6K$4M+2.83%
Q4 202515.6K$3M+2.31%
Q3 202515.6K$3M+2.12%
Q2 202515.6K$2M+1.82%
Q1 202515.6K$3M+2.07%
Q4 202415.6K$2M+1.80%
Q3 202215.9K$3M+3.16%
Q2 202215.9K$3M+3.37%
Q1 202215.9K$3M+3.02%
Q4 202115.9K$3M+2.96%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enhancing Capital LLC’s full portfolio or all institutional holders of JNJ.